UK news

Voy at-home test kit adverts banned over low testosterone claims

Voy at-home test kit adverts banned over low testosterone claims

The Advertising Standards Authority (ASA) has banned five advertisements from the online healthcare provider Voy for making misleading claims related to low testosterone in men. These ads, which included three posters and two paid Facebook promotions, advertised Voy’s at-home testosterone blood testing kits. The ASA criticized the adverts for suggesting a direct link between common symptoms such as irritability and fatigue and low testosterone levels, which the regulator deemed misleading.

Voy responded by withdrawing the adverts during the ASA’s investigation and stated that it will not run them again. According to the NHS, testosterone levels naturally decline as men age, but this decrease is “unlikely” to cause problems by itself. The NHS further notes that while testosterone deficiency in older men can sometimes be associated with symptoms like depression, reduced sex drive, erectile dysfunction, and other physical or emotional issues, these symptoms are not always caused by low testosterone.

Some of Voy’s advertisements had sparked negative reactions when they were displayed on the London Underground earlier this year. Phrases like “It’s not him, it’s his hormones” and “Men get hormonal too” were described by critics as “ragebait.” Voy defended the campaign by saying its goal was to destigmatize conversations about men’s health. However, the ASA contested that the adverts overstated the association between various common symptoms and low testosterone, citing examples like low energy, loss of motivation, low sex drive, and mood changes. The regulator stated that while certain symptoms might be linked to low testosterone, others were nonspecific and should not have been portrayed as definitive indicators.

The ASA also highlighted that one Facebook advert claimed “low testosterone sneaks up on 1 in 4 men over 30,” a statement the watchdog found misleading and unsupported by the evidence provided by Voy. Dr. Earim Chaudry, Voy’s chief medical officer, emphasized that all patient decisions are clinician-led and that the company continuously reviews its advertising to remain compliant with UK standards. This ruling adds to previous decisions made by the ASA in August related to similarly misleading advertisements from BioID Health and Numan Digital Healthcare, all part of a broader investigation into men’s health-related advertising. The watchdog noted a pattern of advertisers exploiting insecurities surrounding libido, erectile dysfunction, testosterone, and aging, insisting that while adverts for related tests are allowed, they must be accurate and evidence-based. Dr. Richard Quinton, an expert on testosterone deficiency, commented on the ease of obtaining low testosterone readings due to factors such as timing of blood tests and health status, highlighting the complexity of diagnosis

Read the original at The BBC

On air now

Low-Fi Lounge

Danger DangerDom Dolla, Solomun, Skepta · Low-Fi Lounge

LIVE